Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists-Reference-Cited by-同舟云学术

Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists

Published:1997-03 Issue:12 Volume:272 Page:8071-8076
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Mukherjee Ranjan,Jow Lily,Croston Glenn E.,Paterniti James R.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference40 articles.

1. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

2. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

3. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.

4. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

Cited by 393 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Tumor Suppressor Par-4 Regulates Adipogenesis by Transcriptional Repression of PPARγ;Cells;2024-09-05

2. Construction of an antidepressant priority list based on functional, environmental, and health risks using an interpretable mixup-transformer deep learning model;Journal of Hazardous Materials;2024-08

3. The Peroxisome Proliferator-Activated Receptors of Ray-Finned Fish: Unique Structures, Elusive Functions;Biomolecules;2024-05-29

4. Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disorders;Cell Communication and Signaling;2024-02-15

5. Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression;Clinical Nutrition;2024-02